The Role of Metabolic Surgery on Blood Pressure Control

被引:0
作者
Carlos Aurelio Schiavon
Luciano F. Drager
Luiz A. Bortolotto
Celso Amodeo
Dimas Ikeoka
Otávio Berwanger
Ricardo Vitor Cohen
机构
[1] Hospital do Coração (HCor),Instituto do Coração (InCor), Hospital das Clínicas
[2] Faculdade de Medicina da USP,Instituto de Pesquisa
[3] Instituto Dante Pazzanese de Cardiologia,The Center for Obesity and Diabetes
[4] Hospital do Coração (HCor),undefined
[5] Oswaldo Cruz German Hospital,undefined
来源
Current Atherosclerosis Reports | 2016年 / 18卷
关键词
Hypertension; Bariatric surgery; Metabolic surgery; Blood pressure; Roux-en-Y gastric bypass; Sleeve gastrectomy;
D O I
暂无
中图分类号
学科分类号
摘要
Obesity and hypertension are growing epidemics in the modern world. Lifestyle changes and medical treatment for obesity have disappointing long-term results and albeit drugs for hypertension are usually very effective, the necessity of multiple pills and frequent side effects make the adherence to treatment a huge challenge for healthcare systems. Bariatric/metabolic surgery is a very effective treatment and an exponential number of studies have been showing its positive impact beyond weight loss, mainly on type 2 diabetes. There is also growing evidence suggesting that bariatric/metabolic surgery is associated with reduced incidence of cardiovascular events, but the impact on hypertension and other components of metabolic syndrome usually derive from trials’ secondary end points. Taking this limitation in mind, bariatric/metabolic surgery action on blood pressure is reaching a significant proportion of hypertension resolution or improvement. In this review, we discussed the current evidence on the impact of bariatric/metabolic surgery on blood pressure control and pointed out perspectives in this research area.
引用
收藏
相关论文
共 96 条
  • [1] Brown CD(2000)Body mass index and the prevalence of hypertension and dyslipidemia Obes Res 8 605-19
  • [2] Higgins M(2007)Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome components: the Coronary Artery Risk Development in Young Adults Study Circulation 115 1004-11
  • [3] Donato KA(2012)Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment J Clin Hypertens 15 14-33
  • [4] Lloyd-Jones DM(2014)Weight loss, saline loading, and the natriuretic peptide system J Am Heart Assoc 4 e001265-76
  • [5] Liu K(2013)Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome J Am Coll Cardiol 62 569-7
  • [6] Colangelo LA(2011)Recent advances of the impact of obstructive sleep apnea on systemic hypertension Arq Bras Cardiol 97 e40-7
  • [7] Landsberg L(2016)Effectiveness of continuous positive airway pressure in lowering blood pressure in patients with obstructive sleep apnea: a critical review of the literature IBPC Vol 9 43-92
  • [8] Aronne LJ(2006)Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome J Clin Invest 116 1784-32
  • [9] Beilin LJ(2013)Adiponectin levels and the risk of hypertension: a systematic review and meta-analysis Hypertension 62 27-4
  • [10] Arora P(1983)Improvement in heart disease risk factors after gastric bypass Arch Surg 118 681-37